![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel | Konferenzbeitrag
Anzahl der Publikationen: 19
Zeitschriftenartikel
Hehlmann, Rüdiger und Lauseker, Michael 
ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies.
In: Leukemia, Bd. 38, Nr. 2: S. 465-466
[PDF, 286kB]
ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies.
In: Leukemia, Bd. 38, Nr. 2: S. 465-466
[PDF, 286kB]
Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Hehlmann, Rüdiger; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2023):
Survival with chronic myeloid leukaemia after failing milestones.
In: Leukemia, Bd. 37: S. 2231-2236
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6662-7127; Hehlmann, Rüdiger; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2023):
Survival with chronic myeloid leukaemia after failing milestones.
In: Leukemia, Bd. 37: S. 2231-2236
[PDF, 1MB]
Niederwieser, Dietger ORCID: https://orcid.org/0000-0002-4737-1103; Lang, Thomas; Krahl, Rainer; Heinicke, Thomas; Maschmeyer, Georg; Al-Ali, Haifa Kathrin; Schwind, Sebastian; Jentzsch, Madlen; Cross, Michael; Kahl, Christoph; Wolf, Hans-Heinrich; Sayer, Herbert; Schulze, Antje; Dreger, Peter; Hegenbart, Ute; Krämer, Alwin; Junghanss, Christian; Mügge, Lars-Olof; Hähling, Detlev; Hirt, Carsten; Späth, Christian; Peter, Norma; Opitz, Bernhard; Florschütz, Axel; Reifenrath, Kolja; Zojer, Niklas; Scholl, Sebastian; Pönisch, Wolfram; Heyn, Simone; Vucinic, Vladan; Hochhaus, Andreas; Aul, Carlo; Giagounidis, Aristoteles; Balleisen, Leopold; Oldenkott, Bernd; Staib, Peter; Kiehl, Michael; Schütte, Wolfgang; Naumann, Ralph; Eimermacher, Hartmut; Dörken, Bernd; Sauerland, Cristina; Lengfelder, Eva; Hiddemann, Wolfgang; Wörmann, Bernhard; Müller-Tidow, Carsten; Serve, Hubert; Schliemann, Christoph; Hehlmann, Rüdiger; Berdel, Wolfgang E.; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Krug, Utz und Hoffmann, Verena S. ORCID: https://orcid.org/0000-0003-1478-5390
(2023):
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
In: Annals of Hematology, Bd. 102: S. 547-561
[PDF, 3MB]
ORCID: https://orcid.org/0000-0002-4737-1103; Lang, Thomas; Krahl, Rainer; Heinicke, Thomas; Maschmeyer, Georg; Al-Ali, Haifa Kathrin; Schwind, Sebastian; Jentzsch, Madlen; Cross, Michael; Kahl, Christoph; Wolf, Hans-Heinrich; Sayer, Herbert; Schulze, Antje; Dreger, Peter; Hegenbart, Ute; Krämer, Alwin; Junghanss, Christian; Mügge, Lars-Olof; Hähling, Detlev; Hirt, Carsten; Späth, Christian; Peter, Norma; Opitz, Bernhard; Florschütz, Axel; Reifenrath, Kolja; Zojer, Niklas; Scholl, Sebastian; Pönisch, Wolfram; Heyn, Simone; Vucinic, Vladan; Hochhaus, Andreas; Aul, Carlo; Giagounidis, Aristoteles; Balleisen, Leopold; Oldenkott, Bernd; Staib, Peter; Kiehl, Michael; Schütte, Wolfgang; Naumann, Ralph; Eimermacher, Hartmut; Dörken, Bernd; Sauerland, Cristina; Lengfelder, Eva; Hiddemann, Wolfgang; Wörmann, Bernhard; Müller-Tidow, Carsten; Serve, Hubert; Schliemann, Christoph; Hehlmann, Rüdiger; Berdel, Wolfgang E.; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Krug, Utz und Hoffmann, Verena S. ORCID: https://orcid.org/0000-0003-1478-5390
(2023):
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
In: Annals of Hematology, Bd. 102: S. 547-561
[PDF, 3MB]
Hehlmann, Rüdiger; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Voskanyan, Astghik; Fabarius, Alice; Haferlach, Claudia ORCID: https://orcid.org/0000-0002-6333-5049; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2022):
Impact of emerging ACA on survival in chronic myeloid leukemia (CML).
In: Leukemia, Bd. 36: S. 2544-2547
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6662-7127; Voskanyan, Astghik; Fabarius, Alice; Haferlach, Claudia ORCID: https://orcid.org/0000-0002-6333-5049; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2022):
Impact of emerging ACA on survival in chronic myeloid leukemia (CML).
In: Leukemia, Bd. 36: S. 2544-2547
[PDF, 1MB]
Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael und Pfirrmann, Markus
(2020):
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
In: Leukemia, Bd. 34, Nr. 10, 2823
Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus; Hasford, Jörg und Kolb, Hans-Jochem
(2020):
High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
In: Leukemia, Bd. 34: S. 2074-2086
[PDF, 1MB]
Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W.; Hofmann, Wolf-Karsten; Hasford, Joerg; Pfirrmann, Markus; Müller, Martin C.; Hochhaus, Andreas und Lauseker, Michael
(2018):
Defining therapy goals for major molecular remission in chronic myeloid leukemia: Results of the randomized CML Study IV.
In: Leukemia, Bd. 32, Nr. 5: S. 1222-1228
[PDF, 599kB]
Schütz, C.; Inselmann, S.; Saussele, Susanne; Dietz, C. T.; Müller, M. C.; Eigendorff, E.; Brendel, C. A.; Metzelder, S. K.; Brümmendorf, T. H.; Waller, C.; Dengler, J.; Goebeler, M. E.; Herbst, R.; Freunek, G.; Hanzel, S.; Illmer, Thomas; Wang, Y.; Lange, T.; Finkernagel, F.; Hehlmann, Rüdiger; Huber, M.; Neubauer, A.; Hochhaus, Andreas; Guilhot, Joelle; Mahon, F. X.; Pfirrmann, Markus und Burchert, A.
(2018):
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
In: Leukemia, Bd. 32, Nr. 4
Hehlmann, Rüdiger; Lauseker, Michael; Saußele, Susanne; Hochhaus, Andreas; Hasford, Joerg; Pfirrmann, Markus; Kolb, Hans-Jochem; Spiekermann, Karsten; Fabarius, Alice; Müller, M. C.; Proetel, Ulrike; Kohlbrenner, K.; Voskanyan, A.; Rinaldetti, S.; Seifarth, W.; Spieß, B.; Krause, S. W.; Neubauer, A.; Burchert, A.; Hossfeld, Dieter K.; Schafhausen, P.; Nerl, C.; Gratwohl, A.; Heim, D.; Baerlocher, Gabriela M.; Brümmendorf, Tim H.; Fuchs, R.; Haferlach, C.; Jeromin, S.; Schlegelberger, Brigitte; Balleisen, L.; Goebeler, M. C.; Hänel, M.; Ho, A.; Dengler, J.; Falge, C.; Kanz, L.; Kremers, S.; Kneba, M.; Stegelmann, F.; Köhne, C. A.; Lindemann, H. W.; Waller, C. F.; Pfreundschuh, Michael; Berdel, Wolfgang E.; Müller, L.; Edinger, M.; Mayer, J.; Beelen, D. W.; Bentz, M.; Link, H.; Hertenstein, Bernd; Wernli, Martin; Schlegel, F.; Schlag, R.; Wit, M. de; Trumper, L.; Hebart, H.; Hahn, M.; Thomalla, J.; Scheid, C.; Verbeek, W.; Eckart, M. J.; Gassmann, W.; Pezzutto, A.; Schenk, M.; Brossart, P.; Geer, T.; Bildat, S. und Schäfer, E.
(2017):
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
In: Leukemia, Bd. 31, Nr. 11: S. 2398-2406
Hoffmann, Verena S.; Hasford, Jörg; Deininger, Michael; Cortes, Jörge; Baccarani, Michele und Hehlmann, Rüdiger
(2017):
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia.
In: Journal of Cancer Research and Clinical Oncology, Bd. 143, Nr. 7: S. 1311-1318
Lauseker, Michael; Hasford, Joerg; Saussele, Susanne; Kremers, Stephan; Kraemer, Doris; Lindemann, Walter; Hehlmann, Rüdiger und Pfirrmann, Markus
(2017):
Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death.
In: Cancer, Bd. 123, Nr. 13: S. 2467-2471
Lauseker, Michael; Hanfstein, Benjamin; Haferlach, Claudia; Schnittger, Susanne; Pfirrmann, Markus; Fabarius, Alice; Schlegelberger, Brigitte; Saußele, Susanne; Dietz, Christian T.; Erben, Philipp; Hehlmann, Rüdiger; Hasford, Joerg; Hochhaus, Andreas und Müller, Martin C.
(November 2014):
Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase.
In: Journal of cancer research and clinical oncology, Bd. 140, Nr. 11: S. 1965-1969
Hehlmann, Rüdiger; Hasford, Joerg; Pfirrmann, Markus; Lauseker, Michael; Saußele, Susanne und Hochhaus, Andreas
(September 2014):
Reply to H. Kantarjian et al.
In: Journal of Clinical Oncology, Bd. 32, Nr. 27, 3078-3078
Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C.; Hanfstein, Benjamin; Krause, Stefan W.; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; Pfirrmann, Markus; Hochhaus, Andreas; Hasford, Joerg; Hehlmann, Rüdiger und Saußele, Susanne
(Juli 2014):
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
In: Annals of Hematology, Bd. 93, Nr. 7: S. 1167-1176
[PDF, 985kB]
Lauseker, Michael; Hasford, Joerg; Pfirrmann, Markus und Hehlmann, Rüdiger
(April 2014):
The impact of health care settings on survival time of patients with chronic myeloid leukemia.
In: Blood, Bd. 123, Nr. 16: S. 2494-2496
Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W.; Schubert, Joerg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Jörg; Hofmann, Wolf-Karsten; Hochhaus, Andreas und Müller, Martin C.
(2014):
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.
In: Haematologica, Bd. 99, Nr. 9: S. 1441-1447
[PDF, 784kB]
Hehlmann, Rüdiger; Hochhaus, Andreas; Kolb, Hans-Jochem; Hasford, Joerg; Gratwohl, Alois; Heimpel, Hermann; Siegert, Wolfgang; Finke, Jürgen; Ehninger, Gerhard; Holler, Ernst; Berger, Ute; Pfirrmann, Markus; Muth, Alexander; Zander, Alex; Fauser, Axel A.; Heyll, Axel; Nerl, Christoph; Hossfeld, Dieter K.; Löffler, Helmut; Pralle, Hans; Queißer, Wolfgang und Tobler, Andreas
(1. Dezember 1999):
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
In: Blood, Bd. 94, Nr. 11, 10572078: S. 3668-3677
Hasford, Joerg; Ansari, H.; Pfirrmann, Markus und Hehlmann, Rüdiger
(Mai 1996):
Analysis and validation of prognostic factors for CML.
In: Bone Marrow Transplantation, Bd. 17, Nr. Supplement 3, 8769702: S. 49-54
Konferenzbeitrag
Lindörfer, Doris; Hoffmann, Verena S.; Rosti, Gianantonio; Castagnetti, Fausto; Saussele, Susanne; Guilhot, Joelle; Simonsson, Bengt; Steegmann, Juan Luis; Mayer, Jiri; Indrak, Karel; Turkina, Anna G; Zaritskey, Andrey; Labar, Boris; Zupan, Irena P; Thielen, Noortje; Clark, Richard E; Thaler, Josef; Melanthiou, Frederiki; Everaus, Hele; Porkka, Kimmo; Bogdanovic, Andrija; Schubert-Fritschle, Gabriele; Panagiotidis, Panagiotis; Masszi, Tamas; Lejniece, Sandra; Griskevicius, Laimonas; Hellmann, Andrzej; Prejzner, Witold; Sacha, Tomasz; Almeida, Antonio; Dyagil, Iryna; Colita, Adriana; Mihaylov, Georgi; Hehlmann, Rüdiger; Hasford, Joerg und Baccarani, Michele
(Juni 2014):
The EUTOS population-based registry: evaluation of baseline characteristics and first treatment choices of 2983 newly diagnosed chronic myeloid leukemia (CML) patients from 20 European countries.
19th Congress of the European Hematology Association (EHA), Mailand, Italien, 12. – 15. Juni 2014.
Haematologica.
Bd. 99, Nr. Suppl. 1
Ferrata Storti Foundation.